Literature DB >> 8092825

Time-survival studies for quantifying effects of azlocillin and tobramycin on Pseudomonas aeruginosa.

M M McFarland1, E M Scott, A Li Wan Po.   

Abstract

Time-survival studies were conducted to estimate the effects of azlocillin and tobramycin on Pseudomonas aeruginosa NCIMB 8295 (in the exponential phase of growth) at concentrations ranging from one-quarter to twice the MIC. The effects of the individual agents and their combinations were determined by measuring the viable counts (CFU per milliliter) over a 24-h period. The typical pattern observed from the plot of the logarithm of the CFU per milliliter against time was an initial rapid killing; this was followed by a period of stasis and regrowth. Initial rates of killing by tobramycin were concentration dependent, whereas this was not the case with azlocillin. From the time-survivor plots, the area under the curve for viable bacteria was also calculated. It offered a useful method of interpreting the results of time-kill studies, taking the overall pattern of killing and regrowth into consideration. The area under the curve for viable bacteria was concentration dependent for both antibiotics. A 2(2) factorial experimental design was used to analyze the joint effects of azlocillin and tobramycin. In such a factorial experiment, an interaction between two factors, in this case, azlocillin and tobramycin concentrations, is shown by a change in the slope of the plot when the concentration of the interactant is changed. Analysis of variance showed that the combination was synergistic at low concentrations, but this was not significant when the concentration of either interactant was increased.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8092825      PMCID: PMC188197          DOI: 10.1128/AAC.38.6.1271

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  Biphasic, concentration-dependent and rate-limited, concentration-independent bacterial killing by an aminoglycoside antibiotic.

Authors:  R D MacArthur; V Lolans; F A Zar; G G Jackson
Journal:  J Infect Dis       Date:  1984-11       Impact factor: 5.226

2.  Mechanisms of aminoglycoside resistance of anaerobic bacteria and facultative bacteria grown anaerobically.

Authors:  L E Bryan; S Kwan
Journal:  J Antimicrob Chemother       Date:  1981-12       Impact factor: 5.790

3.  Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve method.

Authors:  H O Hallander; K Dornbusch; L Gezelius; K Jacobson; I Karlsson
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

4.  Studies of in vitro synergy between several beta-lactam and aminoglycoside antibiotics against endocarditis strains of Pseudomonas aeruginosa.

Authors:  M P Reyes; F Smith; A M Lerner
Journal:  J Infect       Date:  1984-03       Impact factor: 6.072

5.  Synergy of azlocillin with aminoglycosides.

Authors:  N X Chin; H C Neu
Journal:  J Antimicrob Chemother       Date:  1983-05       Impact factor: 5.790

6.  Aminoglycoside-selected subpopulations of Pseudomonas aeruginosa: characterization and virulence in normal and leukopenic mice.

Authors:  A U Gerber; W A Craig
Journal:  J Lab Clin Med       Date:  1982-11

7.  Selection of aminoglycoside-resistant variants of Pseudomonas aeruginosa in an in vivo model.

Authors:  A U Gerber; A P Vastola; J Brandel; W A Craig
Journal:  J Infect Dis       Date:  1982-11       Impact factor: 5.226

8.  Roles of ribosomal binding, membrane potential, and electron transport in bacterial uptake of streptomycin and gentamicin.

Authors:  L E Bryan; S Kwan
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

9.  Activities of tobramycin and azlocillin alone and in combination against experimental osteomyelitis caused by Pseudomonas aeruginosa.

Authors:  C W Norden; M A Shaffer
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

10.  Comparative bactericidal effects of azlocillin and ticarcillin against Pseudomonas aeruginosa.

Authors:  A R White; K R Comber; R Sutherland
Journal:  Antimicrob Agents Chemother       Date:  1980-07       Impact factor: 5.191

View more
  5 in total

1.  Use of decimal assay for additivity to demonstrate synergy in pair combinations of econazole, nikkomycin Z, and ibuprofen against Candida albicans in vitro.

Authors:  V N Tariq; E M Scott; N E McCain
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

2.  Twenty-four-hour area under the concentration-time curve/MIC ratio as a generic predictor of fluoroquinolone antimicrobial effect by using three strains of Pseudomonas aeruginosa and an in vitro pharmacodynamic model.

Authors:  K J Madaras-Kelly; B E Ostergaard; L B Hovde; J C Rotschafer
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

3.  Activities and ultrastructural effects of antifungal combinations against simulated Candida endocardial vegetations.

Authors:  Manjunath P Pai; Marie L Samples; Renee-Claude Mercier; Michael N Spilde
Journal:  Antimicrob Agents Chemother       Date:  2008-04-21       Impact factor: 5.191

4.  Factorial design and post-antibiotic sub-MIC effects of linezolid combined with fosfomycin against vancomycin-resistant enterococci.

Authors:  Yisong Yan; Guang Yang; Yaowen Li; Jun Mao; Shuaishuai Wang; Na Zhang; Huiping Liu; Xiaohui Huang
Journal:  Ann Transl Med       Date:  2022-02

5.  Repurposing celecoxib as a topical antimicrobial agent.

Authors:  Shankar Thangamani; Waleed Younis; Mohamed N Seleem
Journal:  Front Microbiol       Date:  2015-07-28       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.